Freshfields Bruckhaus Deringer has advised ViGeneron GmbH on the deal.ViGeneron GmbH, a next-generation gene therapy company, agreed for a target-specific strategic collaboration and option agreement with Regeneron…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
